<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Medical Case Reports</journalTitle>
<eissn>2374-216X</eissn>
<publicationDate>2021-03-31</publicationDate>
<volume>9</volume>
<issue>7</issue>
<startPage>345</startPage>
<endPage>347</endPage>
<doi>10.12691/ajmcr-9-7-1</doi>
<publisherRecordId>AJMCR2021971</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Metastatic Epithelioid Angiosarcoma of the Spine, Hip, and Femur</title>
<authors>
<author>
<name>Eman EL-Sawalhy</name>
<email>Eman.elsawalhy@beaumont.org</email>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Muna Shaaeli</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Wehbi Hnayni</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Lubna Alattia</name>
<affiliationId>2</affiliationId>
</author>
<author>
<name>Shahina Patel</name>
<affiliationId>3</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Department of Internal Medicine, Beaumont Hospital, Dearborn, MI</affiliationName>


<affiliationName affiliationId="2">Department of Clinical Pathology, Beaumont Hospital, Royal Oak, MI</affiliationName>
<affiliationName affiliationId="3">Division of Hematology & Oncology, Internal Medicine Department, Beaumont Hospital, Dearborn, MI</affiliationName>
</affiliationsList>
<abstract language="eng">Epithelioid Angiosarcoma (EA) is an extremely rare and highly aggressive malignant tumor. It comprises &lt;1 % of all soft tissue sarcomas and is associated with a poor prognosis. In this case report, we are reporting an 85-years-old male who presented with lower back and left hip pain. A computerized tomography (CT) of the lumbar spine and left hip showed a significant fracture of lumbar spine L3 and osteolytic lesions involving the left hip and femur. The patient underwent L1-L5 fusion with cement augmentation and biopsy of L3. Surgical pathology showed a metastatic undifferentiated tumor of unknown primary origin. Histologic analysis of the specimen and immunohistochemistry confirmed EA. Given extensive diffuse bone involvement, our patient was not a candidate for definitive surgical treatment.</abstract>
<fullTextUrl format="pdf">http://pubs.sciepub.com/ajmcr/9/7/1/ajmcr-9-7-1.pdf</fullTextUrl>
<keywords language="eng"><keyword>Epithelioid Angiosarcoma</keyword>
<keyword>bone</keyword>
<keyword>surgical resection</keyword>
<keyword>Tazemetostat</keyword>
</keywords>
</record>
</records>
